Pfizer's goal to provide affordable medicines to 45 poor nations struggles with bureaucracy, reaching only 10 countries so far.

Kansas has filed a lawsuit against Pfizer, accusing the pharmaceutical giant of misleading the public about its COVID-19 vaccine.

Stanford University's study on Pfizer's antiviral Paxlovid finds no significant relief for long COVID-19 symptoms, prompting ongoing investigation into its potential effects on persistent symptoms in a groundbreaking clinical trial.

Pfizer has announced that its cancer drug, Lorbrena, is projected to generate over $1 billion in annual sales by 2030.

Pfizer has announced a multi-year cost-cutting program focusing on operational efficiencies, network structure changes, and product portfolio enhancements, aiming to save $1.5 billion by 2027 amidst declining COVID-19 vaccine sales.

Pfizer and AstraZeneca have announced massive investments in France totaling nearly $1 billion. Two major pharmaceutical companies, Pfizer and AstraZeneca, announced on Sunday massive investments in France totaling nearly $1 billion.

Pfizer has agreed to settle over 10,000 lawsuits concerning the alleged connection between its product, Zantac, and cancer.

Pfizer has agreed to settle over 10,000 lawsuits concerning its Zantac heartburn medication after it was found that a cancer risk was not disclosed.

A recent study conducted by the Centers for Disease Control and Prevention (CDC) has revealed that there is no link between COVID-19 vaccines and cardiac death in younger adults.

Pfizer is shifting its focus from COVID-related products to cancer drugs. Pfizer is shifting its focus on cancer drugs as the pharmaceutical giant tries to recover from a challenging period due to the decline of its COVID-19 business.